Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

53
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
53
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

14.4K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
14.4K
T Cell Types and Functions01:24

T Cell Types and Functions

3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synaptophysin autoantibodies mediate synaptic dysfunction in cerebellar ataxia.

Cell reports. Medicine·2026
Same author

Triggering multiple sclerosis: infection with Epstein-Barr virus activates multiple pre-existing autoreactive B and T cells.

Signal transduction and targeted therapy·2026
Same author

External validation of a multiple sclerosis treatment decision score using data from the ProVal-MS cohort study.

Therapeutic advances in neurological disorders·2025
Same author

CD20+ natural killer cells are polyfunctional, memory-like cells that are enriched in inflammatory disorders.

Journal of immunology (Baltimore, Md. : 1950)·2025
Same author

Continuous temperature monitoring in patients with spontaneous intracerebral hemorrhage: insights into temperature patterns and variability.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2025
Same author

BTK-Inhibition Enhances TLR-7-Mediated Interferon-Alpha Production in pDCs by Blocking the Inhibitory BDCA-2 Pathway.

European journal of immunology·2025

Related Experiment Video

Updated: Apr 29, 2026

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K

B cells in MS and NMO: pathogenesis and therapy.

Markus Krumbholz1, Edgar Meinl

  • 1Institute of Clinical Neuroimmunology, Ludwig Maximilian University of Munich, Max-Lebsche-Platz 31, 81377, Munich, Germany, markus.krumbholz@med.uni-muenchen.de.

Seminars in Immunopathology
|May 17, 2014
PubMed
Summary

B cells play a dual role in multiple sclerosis (MS) and neuromyelitis optica (NMO), exhibiting both pro-inflammatory and regulatory functions. Understanding these complex roles and targeting B cells offers new therapeutic avenues for these autoimmune diseases.

More Related Videos

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

9.9K
An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

6.5K

Related Experiment Videos

Last Updated: Apr 29, 2026

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K
Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

9.9K
An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

6.5K

Area of Science:

  • Neuroimmunology
  • Autoimmune Diseases
  • Cellular Immunology

Background:

  • B lineage cells are implicated in the pathogenesis of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMO).
  • Recent discoveries highlight novel autoantibody targets and expand understanding of B cell roles in antigen presentation and cytokine production.
  • Evidence suggests a loss of B cell self-tolerance in MS, with B cell clones exchanged between cerebrospinal fluid (CSF) and blood.

Purpose of the Study:

  • To review the multifaceted roles of B cells in MS and NMO pathogenesis.
  • To discuss B cell contributions, including pro-inflammatory and regulatory functions, and impaired immune tolerance.
  • To explore the B cell-supportive microenvironment within the central nervous system (CNS) and current therapeutic strategies.

Main Methods:

  • Review of recent scientific literature on B cell involvement in MS and NMO.
  • Analysis of immunogenetic data regarding B cell clone exchange.
  • Examination of the role of cytokines like BAFF and APRIL in B cell survival within the CNS.

Main Results:

  • B cells exhibit both pro-inflammatory and anti-inflammatory (e.g., IL-10, IL-35) functions in MS and NMO.
  • The CNS microenvironment, supported by BAFF and APRIL, promotes B cell survival.
  • An unexpected increase in relapses with atacicept suggests complex involvement of the BAFF/APRIL system.

Conclusions:

  • B cells are critical players in MS and NMO, with both detrimental and potentially beneficial functions.
  • Therapeutic strategies targeting B cells, such as CD20 depletion and complement inhibition, are advancing.
  • Further research is needed to fully elucidate the complex B cell-CNS interactions and optimize targeted therapies.